SynthesisJournal of neurology2025

Clinical outcomes after switching from fingolimod to B-cell-depleting therapies in multiple sclerosis: systematic review and meta-analysis.

Pedro Henrique de Souza Wagner et al.PubMed ↗Publisher ↗

No numbers read from the abstract.